Mikaus 500mg Injection
Marketer
Medius Biotech
Salt Composition
Amikacin (500mg)
Overview Mikaus 500mg Injection
Cefamikacin 500mg Injection combats a broad spectrum of bacterial infections, including those affecting the urinary tract, skeletal system, lungs (such as pneumonia), central nervous system, and bloodstream. This antibiotic is also employed prophylactically in hospitalized individuals to avert infections. Its mechanism involves inhibiting bacterial proliferation. Administration, via intravenous infusion or intramuscular injection, must be performed by a healthcare provider; self-administration is strictly prohibited. Adherence to the prescribed dosage schedule, with evenly spaced intervals, is crucial. Completion of the entire course is vital, even with symptom improvement, as premature cessation may result in recurrence or exacerbation of the infection. Common adverse effects include localized injection reactions and elevated blood urea nitrogen. Persistent side effects or lack of therapeutic response necessitate consultation with a physician. High-dose therapy may rarely cause vertigo, nephrotoxicity, and ototoxicity. Consequently, strict adherence to medical guidance is imperative, potentially involving regular monitoring of renal function, hearing, and urine analysis. Use during pregnancy is contraindicated; disclose pregnancy, pregnancy intentions, or breastfeeding to your doctor.
Uses of Mikaus 500mg Injection
Infections caused by bacteria
Major Benefits of Mikaus 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mikaus 500mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mikaus 500mg Injection:
Administering this medication will be done by your physician or their nursing staff; self-medication is strictly prohibited.
How Mikaus 500mg Injection works:
Cefamikacin 500mg Injection is a bactericidal antibiotic that inhibits bacterial protein synthesis, thereby disrupting crucial cellular processes.
SAFETY ADVICE
AlcoholSAFE
Mikaus 500mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Mikaus 500mg Injection to pregnant individuals poses a confirmed risk to the fetus, precluding its routine use. Nevertheless, in exceptional circumstances involving a life-threatening condition, a physician might deem its use justified if the potential advantages outweigh the inherent dangers. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Administration of Mikaus 500mg Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Administration of Mikaus 500mg Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Individuals with impaired kidney function should use Mikaus 500mg Injection cautiously. Dosage modification of Mikaus 500mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Mikaus 500mg Injection appears to pose minimal risk for individuals with hepatic impairment. Preliminary findings indicate dose modification may be unnecessary. Physician consultation is recommended.
What if you forget to take Mikaus 500mg Injection :
Omitting a scheduled dose of Mikaus 500mg Injection necessitates contacting your physician.
Facts to Know About Mikaus 500mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
| Action Class | Aminoglycoside antibiotics |
3,018 People bought this recently